Differential gene expression in acute lymphoblastic leukemia cells surviving allogeneic transplant

Cancer Immunology, Immunotherapy

Volumn 59, Issue 11, 2010, Pages 1633-1644

  Shand, Jessica C ^a   Jansson, Johan ^a,b   Hsu, Yu Chiao ^a   Campbell, Andrew ^a   Mullen, Craig A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b LINNAEUS UNIVERSITY   (Sweden)

Author keywords

Bone marrow transplantation; Graft versus host disease; Graft versus leukemia; Interferon gamma; Leukemia

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GUANOSINE TRIPHOSPHATASE; HISTOCOMPATIBILITY 2 T REGION LOCUS 23; INTERFERON INDUCIBLE GUANOSINE TRIPHOSPHATASE 1; LYMPHOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN 6.A; MACROPHAGE ACTIVATION 2 LIKE PROTEIN; RNA; STEM CELL ANTIGEN 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADAPTATION; ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENGRAFTMENT; ENZYME ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GRAFT VERSUS LEUKEMIA EFFECT; HLA MATCHING; IMMUNE RESPONSE; IN VITRO STUDY; LEUKEMIA CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROARRAY ANALYSIS; MINOR HISTOCOMPATIBILITY COMPLEX; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UBIQUITINATION;

ANIMALS; BLOTTING, WESTERN; BONE MARROW TRANSPLANTATION; DRUG DELIVERY SYSTEMS; GENE EXPRESSION PROFILING; GRAFT SURVIVAL; GRAFT VS LEUKEMIA EFFECT; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MINOR HISTOCOMPATIBILITY ANTIGENS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSPLANTATION, HOMOLOGOUS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 77958040073     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-010-0889-y     Document Type: Article

References (37)

1. Dahlke J, Kroger N, Zabelina T, Ayuk F, Fehse N, Wolschke C, Waschke O, Schieder H, Renges H, Kruger W, Kruell A, Hinke A, Erttmann R, Kabisch H, Zander AR (2006) Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation. Bone Marrow Transplant 37:155-163
2. Woolfrey AE, Anasetti C, Storer B, Doney K, Milner LA, Sievers EL, Carpenter P, Martin P, Petersdorf E, Appelbaum FR, Hansen JA, Sanders JE (2002) Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children. Blood 99:2002-2008
3. Munoz A, Diaz-Heredia C, Diaz MA, Badell I, Verdeguer A, Martinez A, Gomez P, Perez-Hurtado JM, Bureo E, Fernandez-Delgado R, Gonzalez-Valentin ME, Maldonado MS (2008) Allogeneic hemopoietic stem cell transplantation for childhood acute lymphoblastic leukemia in second complete remission-similar outcomes after matched related and unrelated donor transplant: a study of the Spanish Working Party for Blood and Marrow Transplantation in Children (Getmon). Pediatr Hematol Oncol 25:245-259
4. Bhojwani D, Kang H, Moskowitz NP, Min DJ, Lee H, Potter JW, Davidson G, Willman CL, Borowitz MJ, Belitskaya-Levy I, Hunger SP, Raetz EA, Carroll WL (2006) Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. Blood 108:711-717
5. Anderson LDMS, Mann S, Savary CA, Mullen CA (2000) Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-host disease. Cancer Res 60:5797-5802
6. Bacher U, Kohlmann A, Haferlach T (2009) Current status of gene expression profiling in the diagnosis and management of acute leukaemia. Br J Haematol 145:555-568
7. Yang JJ, Bhojwani D, Yang W, Cai X, Stocco G, Crews K, Wang J, Morrison D, Devidas M, Hunger SP, Willman CL, Raetz EA, Pui CH, Evans WE, Relling MV, Carroll WL (2008) Genome-wide copy number proiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia. Blood 112:4178-4183
8. Zembutsu H, Yanada M, Hishida A, Katagiri T, Tsuruo T, Sugiura I, Takeuchi J, Usui N, Naoe T, Nakamura Y, Ohno R (2007) Prediction of risk of disease recurrence by genome-wide cDNA microarray analysis in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinibcombined chemotherapy. Int J Oncol 31:313-322
9. Iacobucci I, Lonetti A, Messa F, Cilloni D, Arruga F, Ottaviani E, Paolini S, Papayannidis C, Piccaluga PP, Giannoulia P, Soverini S, Amabile M, Poerio A, Saglio G, Pane F, Berton G, Baruzzi A, Vitale A, Chiaretti S, Perini G, Foa R, Baccarani M, Martinelli G (2008) Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance. Blood 112:3847-3855
10. Young FM, Campbell A, Emo KL, Jansson J, Wang P-Y, Jordan CT, Mullen CA (2008) High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A/ARF mutations retain susceptibility to alloreactive T cells. Biol Blood Marrow Transplant 14:622-630
11. Mori S, El-Baki H, Mullen CA (2003) An analysis of immuno-dominance among minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 31:865-875
12. Anderson LJ, Petropoulos D, Everse LA, Mullen CA (1999) Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine. Cancer Res 59:1525-1530
13. Li C, Wong WH (2001) Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98:31-36
14. Gentleman R, Carey VJ, Huber W, Irizarry RA, Dudroit S (2005) Bioinformatics and computational biology solutions using R and bioconductor. Springer, New York
15. Norris AW, Kahn CR (2006) Analysis of gene expression in pathophysiological states: balancing false discovery and false negative rates. Proc Natl Acad Sci USA 103:649-653
16. Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57
17. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, Loda M, Weber G, Mark EJ, Lander ES, Wong W, Johnson BE, Golub TR, Sugarbaker DJ, Meyerson M (2001) Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 98:13790-13795
18. Cikos S, Bukovska A, Koppel J (2007) Relative quantiication of mRNA: comparison of methods currently used for real-time PCR data analysis. BMC Mol Biol 8:113
19. Henderson SC, Kamdar MM, Bamezai A (2002) Ly-6A.2 expression regulates antigen-specific CD4+ T cell proliferation and cytokine production. J Immunol 168:118-126
20. van de Rijn M, Heimfeld S, Spangrude GJ, Weissman IL (1989) Mouse hematopoietic stem-cell antigen Sca-1 is a member of the Ly-6 antigen family. Proc Natl Acad Sci USA 86:4634-4638
21. Lu L, Ikizawa K, Hu D, Werneck MB, Wucherpfennig KW, Cantor H (2007) Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity 26:593-604
22. Ashkenazi A, Holland P, Eckhardt SG (2008) Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL). J Clin Oncol 26:3621-3630
23. Fakler M, Loeder S, Vogler M, Schneider K, Jeremias I, Debatin KM, Fulda S (2009) Small molecule XIAP inhibitors cooperate with TRAIL to induce apoptosis in childhood acute leukemia cells and overcome Bcl-2-mediated resistance. Blood 113:1710-1722
24. Uthaiah RC, Praefcke GJ, Howard JC, Herrmann C (2003) IIGP1, an interferon-gamma-inducible 47-kDa GTPase of the mouse, showing cooperative enzymatic activity and GTP-dependent multimerization. J Biol Chem 278:29336-29343
25. Boehm U, Guethlein L, Klamp T, Ozbek K, Schaub A, Futterer A, Pfeffer K, Howard JC (1998) Two families of GTPases dominate the complex cellular response to IFN-gamma. J Immunol 161:6715-6723
26. Degrandi D, Konermann C, Beuter-Gunia C, Kresse A, Wurthner J, Kurig S, Beer S, Pfeffer K (2007) Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. J Immunol 179:7729-7740
27. Yang YG, Wang H, Asavaroengchai W, Dey BR (2005) Role of inter-feron-gamma in GVHD and GVL. Cell Mol Immunol 2:323-329
28. Bradfute SB, Graubert TA, Goodell MA (2005) Roles of Sca-1 in hematopoietic stem/progenitor cell function. Exp Hematol 33:836-843
29. Zhang Z-X, Stanford WL, Zhang L (2002) Ly-6A is critical for the function of double negative regulatory T cells. Eur J Immunol 32:1584-1592
30. Holmes C, Stanford WL (2007) Concise review: stem cell antigen-1: expression, function, and enigma. Stem Cells 25:1339-1347
31. Lu L, Kim HJ, Werneck MB, Cantor H (2008) Regulation of CD8+ regulatory T cells: interruption of the NKG2A-Qa-1 interaction allows robust suppressive activity and resolution of autoimmune disease. Proc Natl Acad Sci USA 105:19420-19425
32. Henson ES, Johnston JB, Gibson SB (2008) The role of TRAIL death receptors in the treatment of hematological malignancies. Leuk Lymphoma 49:27-35
33. Chen JJ, Chou CW, Chang YF, Chen CC (2008) Proteasome inhibitors enhance TRAIL-induced apoptosis through the intronic regulation of DR5: involvement of NF-kappa B and reactive oxygen species-mediated p53 activation. J Immunol 180:8030-8039
34. Yang YG, Dey BR, Sergio JJ, Pearson DA, Sykes M (1998) Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12. J Clin Invest 102:2126-2135
35. Asavaroengchai W, Wang H, Wang S, Wang L, Bronson R, Sykes M, Yang YG (2007) An essential role for IFN-gamma in regulation of alloreactive CD8 T cells following allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 13:46-55
36. Wang H, Asavaroengchai W, Yeap BY, Wang MG, Wang S, Sykes M, Yang YG (2009) Paradoxical efects of IFN-gamma in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury. Blood 113:3612-3619
37. Capitini CM, Herby S, Milliron M, Anver MR, Mackall CL, Fry TJ (2009) Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-speciic GVT efect. Blood 113:5002-5009